Filing Flows › Korro Bio (KRRO) › Q4 2025 › vs Q3 2025
Korro Bio (KRRO) Q4 2025 vs Q3 2025 (quarter over quarter)
Korro Bio's revenue rose $202K (+19%) from $1.1M in Q3 2025 to $1.3M in Q4 2025.
Korro Bio, Q4 2025: revenue $1.3M (-43% year over year), net loss $50.0M, operating cash flow −$17.7M. The chart draws each line against Q3 2025, the increases inside each band.
Every line
| Line | Q4 2025 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $1.3M | $1.1M | $202K | +19% |
| Other income, net | $990K | $1.2M | −$186K | -16% |
| Net loss | $50.0M | $18.1M | $32.0M | +177% |
| Costs & expenses | $52.3M | $20.3M | $32.0M | +157% |
| Operating costs | $51.7M | $20.3M | $31.4M | +154% |
| Income tax | $636K | $0 | $636K | — |
| Research & development | $11.0M | $13.8M | −$2.8M | -21% |
| General & admin | $6.2M | $6.5M | −$317K | -5% |
| Operating cash sources | $50.0M | $18.1M | $32.0M | +177% |
| Depreciation | $649K | $1.2M | −$551K | -46% |
| Share-based compensation | $2.1M | $1.8M | $246K | +13% |
| Working capital & other | $29.6M | −$2.1M | $31.8M | — |
| Cash used in operations | $17.7M | $17.2M | $523K | +3% |
| Net loss absorbed | $50.0M | $18.1M | $32.0M | +177% |
Questions
How much did Korro Bio's revenue grow quarter over quarter in Q4 2025?
Korro Bio's revenue rose $202K (+19%) from $1.1M in Q3 2025 to $1.3M in Q4 2025.